Fore Biotherapeutics appoints Bill Hinshaw as new CEO
Fore Biotherapeutics, a biotech company developing novel cancer therapies, announced today that it has appointed Bill Hinshaw as its new Chief Executive Officer and Board member, effective immediately. Mr. Hinshaw succeeds Dr. Shawn M. Leland, who served as Advisor and…